PTC Therapeutics Inc (PTCT)
25.21
-0.20
(-0.79%)
USD |
NASDAQ |
Apr 24, 16:00
24.00
-1.21
(-4.80%)
Pre-Market: 09:17
PTC Therapeutics Cash from Investing (Quarterly): -94.42M for Dec. 31, 2023
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -94.42M |
| September 30, 2023 | -29.60M |
| June 30, 2023 | -23.75M |
| March 31, 2023 | -28.97M |
| December 31, 2022 | 32.44M |
| September 30, 2022 | 136.44M |
| June 30, 2022 | 72.25M |
| March 31, 2022 | 49.04M |
| December 31, 2021 | 68.27M |
| September 30, 2021 | 64.70M |
| June 30, 2021 | 56.06M |
| March 31, 2021 | 30.15M |
| December 31, 2020 | -208.12M |
| September 30, 2020 | -394.21M |
| June 30, 2020 | 142.06M |
| March 31, 2020 | -101.27M |
| December 31, 2019 | -229.00M |
| September 30, 2019 | 30.43M |
| June 30, 2019 | -38.17M |
| March 31, 2019 | -150.50M |
| December 31, 2018 | -24.60M |
| September 30, 2018 | -24.11M |
| June 30, 2018 | 7.744M |
| March 31, 2018 | -1.648M |
| Date | Value |
|---|---|
| December 31, 2017 | -54.04M |
| September 30, 2017 | 19.27M |
| June 30, 2017 | 23.47M |
| March 31, 2017 | 24.42M |
| December 31, 2016 | 23.13M |
| September 30, 2016 | 38.24M |
| June 30, 2016 | 21.00M |
| March 31, 2016 | 22.12M |
| December 31, 2015 | -51.83M |
| September 30, 2015 | -6.284M |
| June 30, 2015 | 16.70M |
| March 31, 2015 | 20.61M |
| December 31, 2014 | -113.18M |
| September 30, 2014 | 48.38M |
| June 30, 2014 | -76.09M |
| March 31, 2014 | -4.267M |
| December 31, 2013 | 5.868M |
| September 30, 2013 | -122.02M |
| June 30, 2013 | -11.66M |
| March 31, 2013 | -0.021M |
| December 31, 2012 | -0.0055M |
| September 30, 2012 | -0.0043M |
| June 30, 2012 | -0.0208M |
| March 31, 2012 | -0.1584M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-394.21M
Minimum
Sep 2020
142.06M
Maximum
Jun 2020
-24.51M
Average
30.15M
Median
Mar 2021
Cash from Investing (Quarterly) Benchmarks
| Sarepta Therapeutics Inc | -64.36M |
| Catalyst Pharmaceuticals Inc | -38.32M |
| Pfizer Inc | -11.00B |
| Geron Corp | 47.57M |
| Perspective Therapeutics Inc | -0.089M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -100.29M |
| Cash from Financing (Quarterly) | 620.48M |
| Free Cash Flow | -279.04M |
| Free Cash Flow Per Share (Quarterly) | -1.705 |
| Free Cash Flow to Equity (Quarterly) | -1.654B |
| Free Cash Flow to Firm (Quarterly) | -84.83M |
| Free Cash Flow Yield | -14.79% |